Truist Financial’s Profound Medical PROF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$290K Hold
50,000
– – ﹤0.01% 2533
2026
Q2
$332K Hold
50,000
– – ﹤0.01% 2474
2026
Q1
$324K Hold
50,000
– – ﹤0.01% 2344
2025
Q4
$394K Hold
50,000
– – ﹤0.01% 2168
2025
Q3
$244K Hold
50,000
– – ﹤0.01% 2428
2025
Q2
$295K Hold
50,000
– – ﹤0.01% 2224
2025
Q1
$291K Hold
50,000
– – ﹤0.01% 2158
2024
Q4
$376K Buy
+50,000
New +$384K ﹤0.01% 2036

Other funds holding PROF

Truist Financial's PROF Position: Q3 2026 in Review

Truist Financial held its Profound Medical (PROF) position steady in Q3 2026 at 50,000 shares worth $290K. The position accounts for ﹤0.01% of the portfolio, ranked #2533.

Truist Financial first reported a position in PROF in Q4 2024 and has held it in 8 quarters since. The position peaked at $394K in Q4 2025. 19 funds tracked by Wall St. Rank hold PROF as of Q3 2026.

  • Truist Financial held 50,000 shares of Profound Medical worth $290K as of Q3 2026.
  • Truist Financial left its Profound Medical share count unchanged in Q3 2026.
  • Profound Medical made up ﹤0.01% of Truist Financial's portfolio in Q3 2026, its #2533 holding.
  • Truist Financial first reported a position in Profound Medical in Q4 2024 and has held it in 8 quarters since.
  • Truist Financial's Profound Medical position peaked at $394K in Q4 2025.
  • 19 funds tracked by Wall St. Rank held Profound Medical as of Q3 2026.

Based on Truist Financial's 13F filing for Q3 2026, filed 30 Oct 2026.